Evidera
Sophie Graham is a Senior Research Associate at Evidera, specializing in Real-World Evidence since October 2016. Responsibilities include conducting observational studies on drug safety and effectiveness, performing feasibility studies to assess data strengths and limitations, utilizing machine learning for treatment pattern analysis from social media, and executing systematic literature reviews for comparative assessments. Prior experience includes a work placement at Novartis focusing on supply chain management and customer service, as well as a research internship at Mindshare within the social media team. Sophie is currently pursuing a Doctor of Philosophy (PhD) in Covid Vaccine Safety and Effectiveness at the London School of Hygiene and Tropical Medicine, having previously earned degrees in Environmental Technology from Imperial College London and Biological Sciences from the University of Bristol.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.